4France EK, Glanz JM, Xu S, et al. Safety of the trivalent inactivated influenza vaccine mong children: a population-based study[J]. Arch Pediatr Adolesc Med, 2004, 158(11): 1031-1036.
5Gorse G J, Belshe RB, Munn NJ. Superiority of live attenuated compared with inactivated influenza a vires vaccines in older, chronically ill adults[J]. Chest, 1991, 100(4): 977-984.
6Stephenson I, Nicholson KG. Influenza: vaccination and treatment[J]. Eur Respir J, 2001, 17(6):1282-1293.
7Epstein SL, Kong W, Misplon JA, et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein[J]. Vaccine, 2005, 23(46-47): 5404- 5410.
8Gething M J, Bye J, Skehel J, et al. Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza vires [J]. Nature, 1980, 287(5780): 301-306.
9Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hongkong influenza haemagglutinin and their involvement in antigenic variation [J]. Nature, 1981, 289(5796): 373-378.
